Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China — Stella

Home/Medulloblastoma/

View on ClinicalTrials.gov

Recruiting

Back to Medulloblastoma trials

Trial locations(1 site)

China

Beijing Tiantan Hosiptal, Beijing, Beijing Municipality

Key details

Sponsor

Beijing Tiantan Hospital

Enrollment target

~400 participants

Started

January 2023

Primary completion

December 2027

Age range

0 Years – 18 Years

Last updated January 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.